Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: billy d who wrote (968)	7/6/1998 11:28:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

Billy, How about 50 by 7/17? That way my July SEPR $50 calls will actually become worth something! My concern now is that we may not have enough steam to blast through the roadblock formed by the 4 million additonal shares that theoretically come into existence when the stock goes over $47.50 a share. The $189 convertible note issue is convertible at right around $47.50. I think it will take one more piece of good news to blast this thing through the above --- say some positive news on their Oxybutynin study.